Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
gene therapy
3
×
indiana blog main
indiana top stories
life sciences
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biogen
biotech
bristol-myers squibb
deals
eli lilly
fda
glaxosmithkline
johnson & johnson
novartis
sarepta therapeutics
satsuma pharmaceuticals
What
bio
news
3
×
roundup
drug
drugs
fda
road
approval
aren’t
august
biogen’s
biopharmaceutical
biotech
busy
companies
convo
days
decisions
developers
devices
earlier
failures
gene
help
imminent
legacy
littered
long
medicare
moves
nash
new
nods
noteworthy
opioid
past
patients
price
prices
regulatory
Language
unset
Current search:
news
×
" gene therapy "
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More